C.M. Bidwell & Associates’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,195
Closed -$38.7K 573
2022
Q4
$38.7K Hold
2,195
0.03% 310
2022
Q3
$33K Buy
+2,195
New +$35.5K 0.03% 302
2022
Q2
Sell
-1,955
Closed -$44K 576
2022
Q1
$44K Buy
+1,955
New +$39.6K 0.03% 297
2021
Q3
Sell
-2,325
Closed -$43K 628
2021
Q2
$43K Sell
2,325
-70
-3% -$1.18K 0.03% 320
2021
Q1
$36K Sell
2,395
-95
-4% -$1.52K 0.03% 326
2020
Q4
$36K Buy
+2,490
New +$30.1K 0.03% 308
2019
Q3
Sell
-2,885
Closed -$34K 489
2019
Q2
$34K Buy
+2,885
New +$29.3K 0.03% 277

Other funds holding MDRX

C.M. Bidwell & Associates's MDRX Position: Q1 2023 in Review

C.M. Bidwell & Associates sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2023, closing a stake of 2,195 shares — an estimated $38.7K sold.

C.M. Bidwell & Associates first reported a position in MDRX in Q2 2019 and held it in 7 quarters. The position peaked at $44K in Q1 2022. 242 funds tracked by Wall St. Rank hold MDRX as of Q1 2023.

  • C.M. Bidwell & Associates reported no remaining Veradigm Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 2,195 Veradigm Inc. Common Stock shares in Q1 2023, an estimated $38.7K.
  • C.M. Bidwell & Associates first reported a position in Veradigm Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • C.M. Bidwell & Associates's Veradigm Inc. Common Stock position peaked at $44K in Q1 2022.
  • 242 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2023, filed 12 May 2023.